Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus-Reference-Cited by-同舟云学术

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus

Published:2006-11-24 Issue:1 Volume:20 Page:120-129
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Reichelt Uta,Duesedau Peer,Tsourlakis Maria Ch,Quaas Alexander,Link Björn C,Schurr Paulus G,Kaifi Jussuf T,Gros Stephanie J,Yekebas Emre F,Marx Andreas,Simon Ronald,Izbicki Jakob R,Sauter Guido

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800712.pdf

Reference63 articles.

1. Hynes NE, Lane HA . ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005;5:341–354.

2. Normanno N, Bianco C, Strizzi L, et al. The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets 2005;6:243–257.

3. Rabindran SK . Antitumor activity of HER-2 inhibitors. Cancer Lett 2005;227:9–23.

4. Zhang D, Salto-Tellez M, Do E, et al. Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays. Hum Pathol 2003;34:362–368.

5. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177–182.

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay;Modern Pathology;2024-09

2. Synthesis and evaluation of antibody-drug conjugates with high drug-to-antibody ratio using dimaleimide-DM1 as a linker- payload;Bioorganic Chemistry;2024-08

3. Conformational diversity and protein–protein interfaces in drug repurposing in Ras signaling pathway;Scientific Reports;2024-01-12

4. A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal Adenocarcinoma;Cancers;2024-01-05

5. A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer;Cancers;2023-11-20